MESA LABORATORIES IN...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
MESA LABORATORIES INC /CO logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 381 (as per Q1 2017)no data available
Sector Computer Hardware, TechnologyComputer Hardware, Technologyno data available
Ticker MLABno data available
Financial year endsFY ends End of Marchno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17100120140160180
datesClosing price (adj.)
13.10.2017149.93
11.10.2017157.40
04.10.2017154.96
27.09.2017147.49
20.09.2017149.96
13.09.2017141.07
06.09.2017135.67
30.08.2017135.76
23.08.2017130.76
16.08.2017129.59
09.08.2017136.85
02.08.2017143.79
26.07.2017144.89
19.07.2017154.02
12.07.2017148.27
05.07.2017141.82
27.06.2017139.88
20.06.2017138.17
13.06.2017140.54
06.06.2017163.67
30.05.2017155.81
23.05.2017150.65
16.05.2017144.17
09.05.2017143.40
02.05.2017137.90
25.04.2017141.18
18.04.2017136.17
11.04.2017127.11
04.04.2017124.09
28.03.2017122.27
21.03.2017121.29
14.03.2017120.57
07.03.2017125.72
28.02.2017124.74
21.02.2017124.97
14.02.2017122.77
07.02.2017120.69
31.01.2017118.72
24.01.2017119.93
17.01.2017117.63
10.01.2017124.05
03.01.2017123.31
27.12.2016125.20
19.12.2016125.37
12.12.2016130.04
05.12.2016122.64
28.11.2016128.55
21.11.2016134.21
14.11.2016123.83
07.11.2016119.88
31.10.2016125.64
24.10.2016123.64
17.10.2016116.81
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 149.93n/a
Market Capitalisation
in million USD
 563n/a
Enterprise Value
in million USD
 611n/a
Common Shares Outstanding
as per Jun 30, 2017
 3,758,175n/a
Preferred Shares Outstanding
as per Jun 30, 2017
 n/a
Average Basic Shares Outstanding
TTM
 3,645,250n/a
Average Diluted Shares Outstanding
TTM
 3,816,250n/a
Index Membership
n/a
Business Summary
Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 95n/a
Gross Profit 54n/a
Operating Income 16n/a
EBITDA 25n/a
Net Profit 11n/a
Balance Sheet
Cash and Cash Equivalents 3n/a
Receivables 13n/a
Total Current Assets 34n/a
PP&E 26n/a
Total Assets 169n/a
Accounts Payable 2n/a
Current Debt 1n/a
Total Current Liabilities 15n/a
Long-Term Debt 49n/a
Total Liabilities 68n/a
Total Equity 101n/a
Cash Flow
Depreciation & Amortisation 9n/a
Change in Working Capital -4n/a
Operating Cash Flow 7n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow -14n/a
Dividends Paid -2n/a
Financing Cash Flow 5n/a
Total Change in Cash -2n/a
Free Cash Flow 18n/a
Profitability Ratios
Gross Margin 56.6%n/a
Operating Margin 16.5%n/a
Net Profit Margin 11.3%n/a
Return on Equity 10.7%n/a
Return on Assets 6.4%n/a
Per Share Figures
Basic EPS 2.95n/a
Diluted EPS 2.82n/a
Sales per Share 26.12n/a
Book Value per Share 27.70n/a
FCF per Share 4.98n/a
Dividends per Share 0.65n/a
Price Multiples
Price to Earnings Ratio 50.75n/a
Price to Sales Ratio 5.74n/a
Price to Book Value 5.41n/a
Price to Free Cash Flow 30.08n/a
Valuation Metrics
EV/EBITDA 24.87n/a
EV/Sales 6.42n/a
Book to Market Value 0.18n/a
Other Ratios
Current Ratio 226.1%n/a
Liabilities to Equity Ratio 67.3%n/a
Debt to Assets Ratio 29.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
34
40
46
53
71
85
94
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-15
-16
-18
-21
-28
-33
-40
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
20
24
29
32
43
51
53
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-10
-11
-16
-20
-28
-35
-37
Selling, General & Administrative
-8
-9
-14
-18
-24
-31
-33
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-1
-1
-2
-2
-3
-4
-4
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
10
13
13
12
16
16
16
Non-Operating Income (Loss)
0
0
0
1
-1
-1
-2
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
1
-1
-1
-2
Pretax Income (Loss), Adjusted
10
13
13
13
15
16
14
Abnormal Gains (Losses)
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
10
12
13
13
15
16
14
Income Tax (Expense) Benefit, net
-4
-4
-5
-4
-6
-4
-3
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
6
8
8
9
10
11
11
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
6
8
8
9
10
11
11
Minority Interest
0
0
0
0
0
0
0
Net Income
6
8
8
9
10
11
11
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
6
8
8
9
10
11
11
Remarks
restated on Jun 6, 2013 n/a
calculated values,
restated on Jun 4, 2014 n/a
calculated values,
restated on Jun 3, 2015 n/a
calculated values,
restated on Jun 6, 2016 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
4
7
4
6
2
6
6
Cash & Cash Equivalents
4
7
4
6
2
6
6
Short Term Investments
0
0
0
0
0
0
0
Accounts & Notes Receivable
7
6
8
9
12
15
14
Accounts Receivable, Net
7
6
8
9
12
15
14
Notes Receivable, Net
0
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
0
Inventories
6
4
6
8
12
14
14
Raw Materials
0
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
0
Other Short Term Assets
1
1
1
4
3
2
2
Prepaid Expenses
0
0
1
2
1
1
2
Derivative & Hedging Assets
0
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
0
Deferred Tax Assets
1
1
1
2
2
1
0
Income Taxes Receivable
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
0
Total Current Assets
17
19
19
27
30
37
36
Property, Plant & Equipment, Net
7
7
7
8
10
17
26
Property, Plant & Equipment
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
0
Other Long Term Assets
26
24
39
63
78
107
110
Intangible Assets
11
10
15
25
33
41
38
Goodwill
14
14
24
38
45
66
72
Other Intangible Assets
0
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
0
0
0
Total Noncurrent Assets
33
32
46
71
88
124
136
Total Assets
51
51
66
98
117
161
172
Liabilities and owners' equity
Payables & Accruals
4 4331000
4 4262000
5 4662000
8 8329000
9 9123000
13 13188000
10 10031000
Accounts Payable
1 723000
1 573000
1 1010000
2 2019000
3 2503000
3 2823000
2 2168000
Accrued Taxes
1 900000
1 1051000
1 1145000
0 0
1 1208000
2 2240000
1 514000
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
3 2708000
3 2638000
3 2507000
6 6310000
5 5412000
8 8125000
7 7349000
Short Term Debt
6 5600000
0 0
0 0
0 0
3 3000000
3 3000000
1 1125000
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 0
0 0
0 0
2 1886000
3 2534000
8 7783000
5 5411000
Deferred Revenue
0 0
0 0
0 0
2 1886000
1 1314000
3 3026000
4 4117000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
0 0
1 1220000
5 4757000
1 1294000
Total Current Liabilities
10 9931000
4 4262000
5 4662000
10 10215000
15 14657000
24 23971000
17 16567000
Long Term Debt
2 1500000
0 0
4 4000000
17 16500000
23 23250000
42 42250000
54 53675000
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
3 2712000
3 2519000
5 4504000
6 6481000
6 5934000
10 9849000
4 3670000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
3 2712000
3 2519000
2 2364000
5 4861000
5 5122000
5 5419000
4 3554000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 0
0 0
2 2140000
2 1620000
1 812000
4 4430000
0 116000
Total Noncurrent Liabilities
4 4212000
3 2519000
9 8504000
23 22981000
29 29184000
52 52099000
57 57345000
Total Liabilities
14 14143000
7 6781000
13 13166000
33 33196000
44 43841000
76 76070000
74 73912000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
5 5068000
8 8170000
11 11203000
16 15772000
18 17751000
21 21001000
26 25925000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
31 31349000
36 35745000
42 41550000
49 48561000
56 55962000
65 64828000
74 73656000
Other Equity
0 0
0 0
0 0
0 0
0 -234000
-1 -1151000
-2 -1760000
Equity Before Minority Interest
36 36417000
44 43915000
53 52753000
64 64333000
73 73479000
85 84678000
98 97821000
Minority Interest
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
36 36417000
44 43915000
53 52753000
64 64333000
73 73479000
85 84678000
98 97821000
Total Liabilities & Equity
51 50560000
51 50696000
66 65919000
98 97529000
117 117320000
161 160748000
172 171733000
Remarks restated on Jun 29, 2012 n/a restated on Jun 6, 2013 n/a restated on Jun 4, 2014 n/a restated on Jun 3, 2015 n/a restated on Jun 6, 2016 n/a restated on Jun 7, 2017 n/a restated on Aug 1, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
6
8
8
9
10
11
11
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
2
2
3
4
6
7
9
Non-Cash Items
0
1
1
-1
1
-1
-9
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
1
2
-1
0
-6
0
-3
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
9
12
11
12
11
17
8
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-18
-1
-17
-22
-21
-24
-7
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-3
-1
-1
-1
-3
-8
-12
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-21
-1
-18
-23
-23
-32
-18
Dividends Paid
-1
-2
-2
-2
-2
-2
-2
Cash From (Repayment of) Debt
6
-7
4
13
10
19
10
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
1
1
2
2
2
4
Increase in Capital Stock
0
1
1
2
2
2
4
Decrease in Capital Stock
0
-1
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
5
-7
3
12
9
19
11
Net Cash Before Disc. Operations and FX
-7
4
-3
2
-3
4
0
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-7
4
-3
2
-3
4
0
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
-7
4
-3
2
-4
4
0
Remarks
restated on Jun 6, 2013 n/a
calculated values,
restated on Jun 4, 2014 n/a
calculated values,
restated on Jun 3, 2015 n/a
calculated values,
restated on Jun 6, 2016 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
restated on Jun 7, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo